Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
osi-930 vascular endothelial growth factor receptor 1 small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.21 investigational inhibitor
osi-930 vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.27 phase 1 inhibitor
osi-930 vascular endothelial growth factor receptor 2 NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.27 phase 1 unknown
osi-930 tyrosine-protein kinase kit NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.38 phase 1 unknown
osi-930 mast/stem cell growth factor receptor kit small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.38 investigational inhibitor
osi-930 tyrosine-protein kinase kit NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.38 phase 1 inhibitor
osi-930 mast/stem cell growth factor receptor kit small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.38 investigational unknown
click here to return to the previous page